WallStreetZenWallStreetZen

NASDAQ: COLL
Collegium Pharmaceutical Inc Stock Ownership - Who owns Collegium Pharmaceutical?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Collegium Pharmaceutical Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Gino SantiniDirector2026-06-088,700$16.49
$143.46kBuy
John Gordon FreundDirector2026-05-1820$34.05
$681.00Sell
John Gordon FreundDirector2026-05-154,127$34.54
$142.55kSell
John Gordon FreundDirector2026-05-158,700$16.49
$143.46kBuy
Nancy LurkerDirector2026-05-134,500$35.97
$161.86kSell
Garen G. BohlinDirector2026-05-118,700$37.18
$323.49kSell
Garen G. BohlinDirector2026-05-118,700$16.49
$143.46kBuy
David DieterEVP General Counsel2026-03-1813,976$34.92
$488.10kSell
David DieterEVP General Counsel2026-03-178,840$35.72
$315.76kSell
David DieterEVP General Counsel2026-03-096,224$36.65
$228.11kSell

1 of 4

COLL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when COLL insiders and whales buy or sell their stock.

COLL Shareholders

What type of owners hold Collegium Pharmaceutical Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
David Hirsch19.85%6,438,798$229.09MInsider
Rubric Capital Management LP19.39%6,290,486$223.82MInsider
Longitude Capital Partners LLC17.40%5,643,684$200.80MInsider
Blackrock Inc15.83%5,134,027$182.67MInstitution
Skyline Venture Partners V LP15.72%5,099,832$181.45MInsider
Yasunori Kaneko6.63%2,150,186$76.50MInsider
Frazier Healthcare VI LP5.82%1,887,332$67.15MInsider
Patrick J. Heron5.82%1,887,332$67.15MInsider
Janus Henderson Group PLC5.63%1,825,651$64.96MInstitution
Invesco Ltd4.91%1,591,909$56.64MInstitution

1 of 3

COLL vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
COLL52.48%47.52%Net SellingNet Buying
ALVO5.45%0.00%
PCRX65.03%34.97%Net SellingNet Selling
ETON64.92%33.03%Net SellingNet Selling
CRON13.06%50.58%Net SellingNet Selling
View Top Pharmaceutical Stocks

Collegium Pharmaceutical Stock Ownership FAQ

Who owns Collegium Pharmaceutical?

Collegium Pharmaceutical (NASDAQ: COLL) is owned by 117.07% institutional shareholders, 106.02% Collegium Pharmaceutical insiders, and 0.00% retail investors. David Hirsch is the largest individual Collegium Pharmaceutical shareholder, owning 6.44M shares representing 19.85% of the company. David Hirsch's Collegium Pharmaceutical shares are currently valued at $230.06M.

If you're new to stock investing, here's how to buy Collegium Pharmaceutical stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.